Delivery Order SPE2DB20D1004-SPE2DB24FF2C8
Award Date
1/12/24
Potential Completion Date
1/16/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in 90-count bottles to the Defense Logistics Agency (DLA). The $24,044.29 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of January 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $4,296.28, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA), is a delivery order that provides the federal government with Valsartan-HCTZ 320-25 mg tablets. The contract has a firm fixed price and an ultimate completion date of June 26, 2024. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $4,472.12, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with a period of performance through February 28, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award is for the delivery of Valsartan-HCTZ 320-25 mg tablets, supplied by Amerisourcebergen Drug Corp's Corporate Office division to the Defense Logistics Agency (DLA). The contract, valued at $1,433.39, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of...
This contract award from the Defense Logistics Agency (DLA) is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,106.77 and an ultimate completion date of January 6, 2022. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets to the Defense Logistics Agency (DLA), a major defense agency under the Department of Defense. The $1,731.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,340.11 and is a firm fixed-price delivery order with a completion date of February 5, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the supply of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,165.16. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is July 22, 2024. The contract was not set aside for any specific business type. Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 90 units of the pharmaceutical product Valsartan-HCTZ 320-25 mg tablets. The contract has a completion date of February 5, 2024 and a potential value of $1,295.24. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation or larger contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,312.55 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of August 13, 2024 and does not utilize a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...